Talis Biomedical Stock (NASDAQ: TLIS) stock price, news, charts, stock research, profile.
Open | $9.070 |
Close | - |
Volume / Avg. | 2.698K / 9.127K |
Day Range | 8.771 - 9.070 |
52 Wk Range | 4.350 - 9.320 |
Market Cap | $16.580M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 54 |
Short Interest | 1.14% |
Days to Cover | 1.87 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Talis Biomedical (NASDAQ: TLIS) through any online brokerage.
Other companies in Talis Biomedical’s space includes: Precision Optics Corp (NASDAQ:POCI), Predictive Oncology (NASDAQ:POAI), Nexalin Technology (NASDAQ:NXL), Venus Concept (NASDAQ:VERO) and QT Imaging Holdings (NASDAQ:QTI).
The latest price target for Talis Biomedical (NASDAQ: TLIS) was reported by BTIG on Wednesday, August 16, 2023. The analyst firm set a price target for 5.00 expecting TLIS to fall to within 12 months (a possible -45.05% downside). 1 analyst firms have reported ratings in the last year.
The stock price for Talis Biomedical (NASDAQ: TLIS) is $9.1 last updated April 23, 2024 at 6:42 PM EDT.
There are no upcoming dividends for Talis Biomedical.
Talis Biomedical’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Talis Biomedical.
Talis Biomedical is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.